Status:
COMPLETED
Prospective Randomized Trial of Bactrim on 7 Day Outcome in Patients With Uncomplicated Abscesses
Lead Sponsor:
59th Medical Wing
Collaborating Sponsors:
Emergency Medicine Foundation
Conditions:
Abscesses
Eligibility:
All Genders
16+ years
Phase:
PHASE3
Brief Summary
Patients will be enrolled in a multi-center study to prospectively evaluate outcome after treatment for an uncomplicated skin abscess. All patients will receive incision and drainage and wound culture...
Eligibility Criteria
Inclusion
- Inclusion criteria include all patients age 16 and older who present to the emergency department with a skin abscess that requires incision and drainage.
Exclusion
- Exclusion criteria include patients with diabetes, HIV, cancer or other immunocompromised patients.
- Additionally, any patients who received antibiotics within one week of presentation or were hospitalized in previous month will be excluded to minimize potential confounding variables.
- Pregnant and breastfeeding patients will also be excluded due to possible safety concerns with antibiotic treatment.
- Patients with abscesses on face, perirectal, or perianal regions, abscesses with known tracks or fistulas to deeper structures, or abscesses requiring surgical drainage in an operating room are excluded.
- Patients with fever or evidence of systemic infection
- Finally, patients with sulfa allergy will be excluded.
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
212 Patients enrolled
Trial Details
Trial ID
NCT00973765
Start Date
November 1 2007
End Date
August 1 2009
Last Update
March 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wilford Hall Medical Center
Lackland Air Force Base, Texas, United States